questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines et peptides de signalisation intracellulaire
Protéines adaptatrices de la transduction du signal
Protéines adaptatrices de la transduction du signal : Questions médicales fréquentes
Diagnostic
5
Protéines adaptatrices
Diagnostic médical
Protéines adaptatrices
Tests de laboratoire
Biopsie
Protéines adaptatrices
Marqueurs biologiques
Protéines adaptatrices
Imagerie médicale
Pathologies
Symptômes
5
Symptômes
Protéines adaptatrices
Troubles neurologiques
Protéines adaptatrices
Maladies auto-immunes
Symptômes
Cancers
Protéines adaptatrices
Protéines adaptatrices
Pathologies
Prévention
5
Prévention
Protéines adaptatrices
Dépistage
Protéines adaptatrices
Exercice physique
Protéines adaptatrices
Traitements
5
Thérapies ciblées
Protéines adaptatrices
Médicaments
Protéines adaptatrices
Thérapie génique
Protéines adaptatrices
Traitements immunologiques
Protéines adaptatrices
Essais cliniques
Protéines adaptatrices
Complications
5
Complications
Protéines adaptatrices
Maladies cardiovasculaires
Protéines adaptatrices
Maladies infectieuses
Protéines adaptatrices
Troubles métaboliques
Protéines adaptatrices
Complications neurologiques
Protéines adaptatrices
Facteurs de risque
5
Facteurs de risque
Protéines adaptatrices
Âge
Protéines adaptatrices
Stress oxydatif
Protéines adaptatrices
Antécédents familiaux
Protéines adaptatrices
Toxines
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines adaptatrices de la transduction du signal : Questions médicales les plus fréquentes",
"headline": "Protéines adaptatrices de la transduction du signal : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines adaptatrices de la transduction du signal : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-10",
"dateModified": "2026-06-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines adaptatrices de la transduction du signal"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines et peptides de signalisation intracellulaire",
"url": "https://questionsmedicales.fr/mesh/D047908",
"about": {
"@type": "MedicalCondition",
"name": "Protéines et peptides de signalisation intracellulaire",
"code": {
"@type": "MedicalCode",
"code": "D047908",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéines 14-3-3",
"alternateName": "14-3-3 Proteins",
"url": "https://questionsmedicales.fr/mesh/D048948",
"about": {
"@type": "MedicalCondition",
"name": "Protéines 14-3-3",
"code": {
"@type": "MedicalCode",
"code": "D048948",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.050"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines d'ancrage aux protéines kinases A",
"alternateName": "A Kinase Anchor Proteins",
"url": "https://questionsmedicales.fr/mesh/D054758",
"about": {
"@type": "MedicalCondition",
"name": "Protéines d'ancrage aux protéines kinases A",
"code": {
"@type": "MedicalCode",
"code": "D054758",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.069"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Angiomotines",
"alternateName": "Angiomotins",
"url": "https://questionsmedicales.fr/mesh/D000091082",
"about": {
"@type": "MedicalCondition",
"name": "Angiomotines",
"code": {
"@type": "MedicalCode",
"code": "D000091082",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.087"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines Dishevelled",
"alternateName": "Dishevelled Proteins",
"url": "https://questionsmedicales.fr/mesh/D000072261",
"about": {
"@type": "MedicalCondition",
"name": "Protéines Dishevelled",
"code": {
"@type": "MedicalCode",
"code": "D000072261",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.330"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine adaptatrice GRB2",
"alternateName": "GRB2 Adaptor Protein",
"url": "https://questionsmedicales.fr/mesh/D051380",
"about": {
"@type": "MedicalCondition",
"name": "Protéine adaptatrice GRB2",
"code": {
"@type": "MedicalCode",
"code": "D051380",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.377"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine adaptatrice GRB7",
"alternateName": "GRB7 Adaptor Protein",
"url": "https://questionsmedicales.fr/mesh/D051382",
"about": {
"@type": "MedicalCondition",
"name": "Protéine adaptatrice GRB7",
"code": {
"@type": "MedicalCode",
"code": "D051382",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.379"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine adaptatrice GRB10",
"alternateName": "GRB10 Adaptor Protein",
"url": "https://questionsmedicales.fr/mesh/D051383",
"about": {
"@type": "MedicalCondition",
"name": "Protéine adaptatrice GRB10",
"code": {
"@type": "MedicalCode",
"code": "D051383",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.380"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines d'échafaudage Homer",
"alternateName": "Homer Scaffolding Proteins",
"url": "https://questionsmedicales.fr/mesh/D000072233",
"about": {
"@type": "MedicalCondition",
"name": "Protéines d'échafaudage Homer",
"code": {
"@type": "MedicalCode",
"code": "D000072233",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.381"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Substrats du récepteur à l'insuline",
"alternateName": "Insulin Receptor Substrate Proteins",
"url": "https://questionsmedicales.fr/mesh/D055504",
"about": {
"@type": "MedicalCondition",
"name": "Substrats du récepteur à l'insuline",
"code": {
"@type": "MedicalCode",
"code": "D055504",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.382"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-1 de type kelch associée à ECH",
"alternateName": "Kelch-Like ECH-Associated Protein 1",
"url": "https://questionsmedicales.fr/mesh/D000072019",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-1 de type kelch associée à ECH",
"code": {
"@type": "MedicalCode",
"code": "D000072019",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.387"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur de différenciation myéloïde-88",
"alternateName": "Myeloid Differentiation Factor 88",
"url": "https://questionsmedicales.fr/mesh/D053594",
"about": {
"@type": "MedicalCondition",
"name": "Facteur de différenciation myéloïde-88",
"code": {
"@type": "MedicalCode",
"code": "D053594",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.390"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines adaptatrices de signalisation NOD",
"alternateName": "Nod Signaling Adaptor Proteins",
"url": "https://questionsmedicales.fr/mesh/D053472",
"about": {
"@type": "MedicalCondition",
"name": "Protéines adaptatrices de signalisation NOD",
"code": {
"@type": "MedicalCode",
"code": "D053472",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.391"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines de régulation du métabolisme azoté",
"alternateName": "PII Nitrogen Regulatory Proteins",
"url": "https://questionsmedicales.fr/mesh/D051922",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de régulation du métabolisme azoté",
"code": {
"@type": "MedicalCode",
"code": "D051922",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs de STAT activés",
"alternateName": "Protein Inhibitors of Activated STAT",
"url": "https://questionsmedicales.fr/mesh/D050828",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs de STAT activés",
"code": {
"@type": "MedicalCode",
"code": "D050828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.402"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Séquestosome-1",
"alternateName": "Sequestosome-1 Protein",
"url": "https://questionsmedicales.fr/mesh/D000071456",
"about": {
"@type": "MedicalCondition",
"name": "Séquestosome-1",
"code": {
"@type": "MedicalCode",
"code": "D000071456",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.422"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines adaptatrices de signalisation Shc",
"alternateName": "Shc Signaling Adaptor Proteins",
"url": "https://questionsmedicales.fr/mesh/D055765",
"about": {
"@type": "MedicalCondition",
"name": "Protéines adaptatrices de signalisation Shc",
"code": {
"@type": "MedicalCode",
"code": "D055765",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.424"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéine transformante-1 contenant un domaine d'homologie-2 de Src",
"alternateName": "Src Homology 2 Domain-Containing, Transforming Protein 1",
"url": "https://questionsmedicales.fr/mesh/D000071425",
"about": {
"@type": "MedicalCondition",
"name": "Protéine transformante-1 contenant un domaine d'homologie-2 de Src",
"code": {
"@type": "MedicalCode",
"code": "D000071425",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.424.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine transformante-2 contenant un domaine d'homologie-2 de Src",
"alternateName": "Src Homology 2 Domain-Containing, Transforming Protein 2",
"url": "https://questionsmedicales.fr/mesh/D000071426",
"about": {
"@type": "MedicalCondition",
"name": "Protéine transformante-2 contenant un domaine d'homologie-2 de Src",
"code": {
"@type": "MedicalCode",
"code": "D000071426",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.424.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine transformante-3 contenant un domaine d'homologie-2 de Src",
"alternateName": "Src Homology 2 Domain-Containing, Transforming Protein 3",
"url": "https://questionsmedicales.fr/mesh/D000071427",
"about": {
"@type": "MedicalCondition",
"name": "Protéine transformante-3 contenant un domaine d'homologie-2 de Src",
"code": {
"@type": "MedicalCode",
"code": "D000071427",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.424.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protéine associée aux molécules de signalisation de l'activation des lymphocytes",
"alternateName": "Signaling Lymphocytic Activation Molecule Associated Protein",
"url": "https://questionsmedicales.fr/mesh/D000071179",
"about": {
"@type": "MedicalCondition",
"name": "Protéine associée aux molécules de signalisation de l'activation des lymphocytes",
"code": {
"@type": "MedicalCode",
"code": "D000071179",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.426"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines Smad inhibitrices",
"alternateName": "Smad Proteins, Inhibitory",
"url": "https://questionsmedicales.fr/mesh/D051897",
"about": {
"@type": "MedicalCondition",
"name": "Protéines Smad inhibitrices",
"code": {
"@type": "MedicalCode",
"code": "D051897",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.428.249"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéine Smad7",
"alternateName": "Smad7 Protein",
"url": "https://questionsmedicales.fr/mesh/D051906",
"about": {
"@type": "MedicalCondition",
"name": "Protéine Smad7",
"code": {
"@type": "MedicalCode",
"code": "D051906",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.428.249.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protéines SOCS",
"alternateName": "Suppressor of Cytokine Signaling Proteins",
"url": "https://questionsmedicales.fr/mesh/D050826",
"about": {
"@type": "MedicalCondition",
"name": "Protéines SOCS",
"code": {
"@type": "MedicalCode",
"code": "D050826",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.437"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéine-1 suppressive de la signalisation des cytokines",
"alternateName": "Suppressor of Cytokine Signaling 1 Protein",
"url": "https://questionsmedicales.fr/mesh/D000071222",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-1 suppressive de la signalisation des cytokines",
"code": {
"@type": "MedicalCode",
"code": "D000071222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.437.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-3 suppressive de la signalisation des cytokine",
"alternateName": "Suppressor of Cytokine Signaling 3 Protein",
"url": "https://questionsmedicales.fr/mesh/D000071223",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-3 suppressive de la signalisation des cytokine",
"code": {
"@type": "MedicalCode",
"code": "D000071223",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.437.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Synténines",
"alternateName": "Syntenins",
"url": "https://questionsmedicales.fr/mesh/D053676",
"about": {
"@type": "MedicalCondition",
"name": "Synténines",
"code": {
"@type": "MedicalCode",
"code": "D053676",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.468"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Transcriptional coactivator with PDZ-binding motif proteins",
"alternateName": "Transcriptional Coactivator with PDZ-Binding Motif Proteins",
"url": "https://questionsmedicales.fr/mesh/D000091364",
"about": {
"@type": "MedicalCondition",
"name": "Transcriptional coactivator with PDZ-binding motif proteins",
"code": {
"@type": "MedicalCode",
"code": "D000091364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.484"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale",
"alternateName": "Tumor Necrosis Factor Receptor-Associated Peptides and Proteins",
"url": "https://questionsmedicales.fr/mesh/D047988",
"about": {
"@type": "MedicalCondition",
"name": "Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale",
"code": {
"@type": "MedicalCode",
"code": "D047988",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Facteur-1 associé aux récepteurs de TNF",
"alternateName": "TNF Receptor-Associated Factor 1",
"url": "https://questionsmedicales.fr/mesh/D047990",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-1 associé aux récepteurs de TNF",
"code": {
"@type": "MedicalCode",
"code": "D047990",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.500.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur-2 associé aux récepteurs de TNF",
"alternateName": "TNF Receptor-Associated Factor 2",
"url": "https://questionsmedicales.fr/mesh/D047992",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-2 associé aux récepteurs de TNF",
"code": {
"@type": "MedicalCode",
"code": "D047992",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.500.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur-3 associé aux récepteurs de TNF",
"alternateName": "TNF Receptor-Associated Factor 3",
"url": "https://questionsmedicales.fr/mesh/D048008",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-3 associé aux récepteurs de TNF",
"code": {
"@type": "MedicalCode",
"code": "D048008",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.500.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur-4 associé aux récepteurs de TNF",
"alternateName": "TNF Receptor-Associated Factor 4",
"url": "https://questionsmedicales.fr/mesh/D053449",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-4 associé aux récepteurs de TNF",
"code": {
"@type": "MedicalCode",
"code": "D053449",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.500.906"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur-5 associé aux récepteurs de TNF",
"alternateName": "TNF Receptor-Associated Factor 5",
"url": "https://questionsmedicales.fr/mesh/D048015",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-5 associé aux récepteurs de TNF",
"code": {
"@type": "MedicalCode",
"code": "D048015",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.500.937"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur-6 associé aux récepteurs de TNF",
"alternateName": "TNF Receptor-Associated Factor 6",
"url": "https://questionsmedicales.fr/mesh/D048029",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-6 associé aux récepteurs de TNF",
"code": {
"@type": "MedicalCode",
"code": "D048029",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.500.968"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protéines de signalisation YAP",
"alternateName": "YAP-Signaling Proteins",
"url": "https://questionsmedicales.fr/mesh/D000091102",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de signalisation YAP",
"code": {
"@type": "MedicalCode",
"code": "D000091102",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines adaptatrices de la transduction du signal",
"alternateName": "Adaptor Proteins, Signal Transducing",
"code": {
"@type": "MedicalCode",
"code": "D048868",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kenji Oritani",
"url": "https://questionsmedicales.fr/author/Kenji%20Oritani",
"affiliation": {
"@type": "Organization",
"name": "Department of Hematology, Graduate School of Medical Science, International University of Health and Welfare, Narita, Japan."
}
},
{
"@type": "Person",
"name": "Tadashi Matsuda",
"url": "https://questionsmedicales.fr/author/Tadashi%20Matsuda",
"affiliation": {
"@type": "Organization",
"name": "Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan."
}
},
{
"@type": "Person",
"name": "Yuichi Kitai",
"url": "https://questionsmedicales.fr/author/Yuichi%20Kitai",
"affiliation": {
"@type": "Organization",
"name": "Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University."
}
},
{
"@type": "Person",
"name": "Jun-Ichi Kashiwakura",
"url": "https://questionsmedicales.fr/author/Jun-Ichi%20Kashiwakura",
"affiliation": {
"@type": "Organization",
"name": "Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University."
}
},
{
"@type": "Person",
"name": "Ryuta Muromoto",
"url": "https://questionsmedicales.fr/author/Ryuta%20Muromoto",
"affiliation": {
"@type": "Organization",
"name": "Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Potential of targeting signal-transducing adaptor protein-2 in cancer therapeutic applications.",
"datePublished": "2024-03-07",
"url": "https://questionsmedicales.fr/article/38745775",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.37349/etat.2024.00216"
}
},
{
"@type": "ScholarlyArticle",
"name": "LYP regulates SLP76 and other adaptor proteins in T cells.",
"datePublished": "2024-09-28",
"url": "https://questionsmedicales.fr/article/39342392",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40659-024-00536-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Role of Signal-Transducing Adaptor Protein-1 for T Cell Activation and Pathogenesis of Autoimmune Demyelination and Airway Inflammation.",
"datePublished": "2024-02-05",
"url": "https://questionsmedicales.fr/article/38315039",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4049/jimmunol.2300202"
}
},
{
"@type": "ScholarlyArticle",
"name": "Role of Sam68 as an adaptor protein in inflammatory signaling.",
"datePublished": "2024-02-14",
"url": "https://questionsmedicales.fr/article/38351330",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00018-023-05108-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Outer membrane protein 25 of Brucella suppresses TLR-mediated expression of proinflammatory cytokines through degradation of TLRs and adaptor proteins.",
"datePublished": "2023-09-29",
"url": "https://questionsmedicales.fr/article/37778729",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbc.2023.105309"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines adaptatrices de la transduction du signal",
"item": "https://questionsmedicales.fr/mesh/D048868"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines adaptatrices de la transduction du signal - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines adaptatrices de la transduction du signal",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines adaptatrices de la transduction du signal",
"description": "Comment diagnostiquer une dysfonction des protéines adaptatrices ?\nQuels tests sont utilisés pour évaluer les protéines adaptatrices ?\nLes biopsies peuvent-elles aider au diagnostic ?\nQuels marqueurs biologiques sont associés aux protéines adaptatrices ?\nLes imageries médicales sont-elles utiles pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D048868#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines adaptatrices de la transduction du signal",
"description": "Quels symptômes sont liés à des anomalies des protéines adaptatrices ?\nLes troubles neurologiques peuvent-ils être causés par ces protéines ?\nY a-t-il des symptômes spécifiques aux maladies auto-immunes ?\nComment les cancers sont-ils liés aux protéines adaptatrices ?\nLes symptômes varient-ils selon le type de protéine adaptatrice ?",
"url": "https://questionsmedicales.fr/mesh/D048868#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines adaptatrices de la transduction du signal",
"description": "Peut-on prévenir les dysfonctionnements des protéines adaptatrices ?\nLes dépistages réguliers sont-ils recommandés ?\nL'évitement de certaines substances peut-il aider ?\nL'exercice physique a-t-il un impact sur la santé des protéines ?\nLes vaccinations peuvent-elles jouer un rôle préventif ?",
"url": "https://questionsmedicales.fr/mesh/D048868#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines adaptatrices de la transduction du signal",
"description": "Quels traitements ciblent les protéines adaptatrices ?\nLes médicaments peuvent-ils moduler l'activité des protéines adaptatrices ?\nLa thérapie génique est-elle une option pour ces dysfonctionnements ?\nLes traitements immunologiques sont-ils efficaces ?\nY a-t-il des essais cliniques en cours ?",
"url": "https://questionsmedicales.fr/mesh/D048868#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines adaptatrices de la transduction du signal",
"description": "Quelles complications peuvent survenir avec des anomalies des protéines ?\nLes maladies cardiovasculaires sont-elles liées aux protéines adaptatrices ?\nY a-t-il un risque accru de maladies infectieuses ?\nLes troubles métaboliques peuvent-ils être une complication ?\nLes complications neurologiques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D048868#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines adaptatrices de la transduction du signal",
"description": "Quels facteurs de risque sont associés aux anomalies des protéines ?\nL'âge est-il un facteur de risque ?\nLe stress oxydatif influence-t-il ces protéines ?\nLes antécédents familiaux jouent-ils un rôle ?\nL'exposition à des toxines est-elle un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D048868#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des protéines adaptatrices ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses protéomiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les protéines adaptatrices ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests d'immunoblot et les essais de liaison sont courants."
}
},
{
"@type": "Question",
"name": "Les biopsies peuvent-elles aider au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent révéler des anomalies dans l'expression des protéines."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques sont associés aux protéines adaptatrices ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme la phospho-protéine peuvent indiquer une activation anormale."
}
},
{
"@type": "Question",
"name": "Les imageries médicales sont-elles utiles pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles ne sont pas directement liées, mais peuvent aider à évaluer des pathologies associées."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à des anomalies des protéines adaptatrices ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes variés comme des troubles immunitaires ou des cancers peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques peuvent-ils être causés par ces protéines ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dysfonctionnements peuvent entraîner des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux maladies auto-immunes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue, les douleurs articulaires peuvent être présents."
}
},
{
"@type": "Question",
"name": "Comment les cancers sont-ils liés aux protéines adaptatrices ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mutations dans ces protéines peuvent conduire à une prolifération cellulaire incontrôlée."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de protéine adaptatrice ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque protéine peut être associée à des pathologies spécifiques."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les dysfonctionnements des protéines adaptatrices ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent réduire les risques."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers sont-ils recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, surtout pour les personnes à risque de maladies associées."
}
},
{
"@type": "Question",
"name": "L'évitement de certaines substances peut-il aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les toxines et les agents cancérigènes peut réduire les risques."
}
},
{
"@type": "Question",
"name": "L'exercice physique a-t-il un impact sur la santé des protéines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la signalisation cellulaire."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles jouer un rôle préventif ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui affectent la signalisation."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les protéines adaptatrices ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies ciblées et des inhibiteurs spécifiques sont en développement."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils moduler l'activité des protéines adaptatrices ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent influencer leur fonction et leur expression."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option pour ces dysfonctionnements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique pourrait corriger des mutations dans les gènes codant ces protéines."
}
},
{
"@type": "Question",
"name": "Les traitements immunologiques sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent aider à restaurer la fonction immunitaire liée aux protéines adaptatrices."
}
},
{
"@type": "Question",
"name": "Y a-t-il des essais cliniques en cours ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, plusieurs essais évaluent de nouvelles thérapies ciblant ces protéines."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des anomalies des protéines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des cancers, des maladies auto-immunes et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Les maladies cardiovasculaires sont-elles liées aux protéines adaptatrices ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dysfonctionnements peuvent contribuer à des maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de maladies infectieuses ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une signalisation altérée peut affaiblir le système immunitaire."
}
},
{
"@type": "Question",
"name": "Les troubles métaboliques peuvent-ils être une complication ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans la signalisation peuvent entraîner des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dysfonctionnements peuvent mener à des troubles neurologiques graves."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés aux anomalies des protéines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs génétiques, environnementaux et liés au mode de vie peuvent jouer un rôle."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'anomalies augmente avec l'âge en raison de l'accumulation de mutations."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif influence-t-il ces protéines ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut altérer la fonction des protéines adaptatrices."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines est-elle un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des substances toxiques peut affecter la signalisation cellulaire."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 30/06/2026
Contenu vérifié selon les dernières recommandations médicales
11 publications dans cette catégorie
Affiliations :
Department of Hematology, Graduate School of Medical Science, International University of Health and Welfare, Narita, Japan.
11 publications dans cette catégorie
Affiliations :
Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
9 publications dans cette catégorie
Affiliations :
Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University.
9 publications dans cette catégorie
Affiliations :
Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University.
8 publications dans cette catégorie
Affiliations :
Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University.
7 publications dans cette catégorie
Affiliations :
Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University.
6 publications dans cette catégorie
Affiliations :
Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University.
5 publications dans cette catégorie
Affiliations :
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan. Electronic address: michii@bldon.med.osaka-u.ac.jp.
Publications dans "Protéines adaptatrices de la transduction du signal" :
5 publications dans cette catégorie
Affiliations :
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan.
Publications dans "Protéines adaptatrices de la transduction du signal" :
5 publications dans cette catégorie
Affiliations :
Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University.
Publications dans "Protéines adaptatrices de la transduction du signal" :
4 publications dans cette catégorie
Affiliations :
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan; Sumitomo Hospital, Osaka, Japan.
Publications dans "Protéines adaptatrices de la transduction du signal" :
4 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720 USA.
Novartis-Berkeley Translational Chemical Biology Institute.
Innovative Genomics Institute, Berkeley, CA 94720 USA.
Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720 USA.
Publications dans "Protéines adaptatrices de la transduction du signal" :
3 publications dans cette catégorie
Affiliations :
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan; Laboratory of Cellular Immunotherapy, World Premier International Immunology Frontier Research Center, Osaka University, Suita, Japan; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Suita, Japan.
Publications dans "Protéines adaptatrices de la transduction du signal" :
3 publications dans cette catégorie
Affiliations :
Department of Hematology, Oncology, Osaka University Graduate School of Medicine, Suita, Japan.
Publications dans "Protéines adaptatrices de la transduction du signal" :
3 publications dans cette catégorie
Affiliations :
Department of Hematology, Oncology, Osaka University Graduate School of Medicine, Suita, Japan.
Publications dans "Protéines adaptatrices de la transduction du signal" :
3 publications dans cette catégorie
Affiliations :
Department of Biosciences & Biomedical Engineering (BSBE), Indian Institute of Technology Indore (IITI), Indore, India.
Publications dans "Protéines adaptatrices de la transduction du signal" :
2 publications dans cette catégorie
Affiliations :
Genome Information Research Center, Res Institute for Microbial Diseases, Osaka University, Japan.
Publications dans "Protéines adaptatrices de la transduction du signal" :
2 publications dans cette catégorie
Affiliations :
Genome Information Research Center, Res Institute for Microbial Diseases, Osaka University, Japan.
Publications dans "Protéines adaptatrices de la transduction du signal" :
2 publications dans cette catégorie
Affiliations :
Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido, Japan.
Publications dans "Protéines adaptatrices de la transduction du signal" :
2 publications dans cette catégorie
Affiliations :
Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido, Japan.
Publications dans "Protéines adaptatrices de la transduction du signal" :
Adaptor proteins play essential roles in various intracellular signaling pathways. Signal-transducing adaptor protein-2 (STAP-2) is an adaptor protein that possesses pleckstrin homology (PH) and Src h...
The LYP tyrosine phosphatase presents a SNP (1858C > T) that increases the risk of developing autoimmune diseases such as type I diabetes and arthritis. It remains unclear how this SNP affects LYP fun...
In this study, we identify in T lymphocytes several adaptor proteins as potential substrates targeted by LYP, including FYB, SLP-76, HS-1, Vav, SKAP1 and SKAP2. We also show that LYP co-localizes with...
These data indicate that LYP may modulate T cell activation by dephosphorylating several adaptor proteins, such as FYB, SLP-76, HS-1, Vav, SKAP1 and SKAP2 upon TCR engagement....
Signal-transducing adaptor protein (STAP)-1 is an adaptor protein that is widely expressed in T cells. In this article, we show that STAP-1 upregulates TCR-mediated T cell activation and T cell-mediat...
Sam68 is a ubiquitously expressed KH-domain containing RNA-binding protein highly studied for its involvement in regulating multiple steps of RNA metabolism. Sam68 also contains multiple protein-prote...
Toll-like receptors (TLRs) are essential components of innate immunity that serves as the first line of defense against the invaded microorganisms. However, successful infectious pathogens subvert TLR...
The chemokine receptor, CXCR4 signaling regulates cell growth, invasion, and metastasis to the bone-marrow niche in prostate cancer (PCa). Previously, we established that CXCR4 interacts with phosphat...
GRB2, or Growth Factor Receptor-Bound Protein 2, is a pivotal adaptor protein in intracellular signal transduction pathways, particularly within receptor tyrosine kinase (RTK) signaling cascades. Its ...
Autophagy is a highly conserved catabolic mechanism by which unnecessary or dysfunctional cellular components are removed. The dysregulation of autophagy has been implicated in various neurodegenerati...
Macrophages are integral part of the body's defense against pathogens and serve as vital regulators of inflammation. Adaptor molecules, featuring diverse domains, intricately orchestrate the recruitme...
The signal transducer and activator of transcription (STAT) family of proteins has been demonstrated to perform pivotal roles downstream of a myriad of cytokines, particularly those that control immun...